This classification is not a treatment recommendation or a guarantee of effect. Evidence evaluation method And research resources You can start by examining it.

Memory, attention and learning

Measured results in cognitive tasks; Read on, taking into account the differences between healthy adults, the elderly and clinical groups. A change in one test does not mean the same magnitude of impact on daily life.

Reading path

  1. Neuroplasticity: mechanisms, human evidence and research limits
  2. Getting Started with Nootropics: Evidence and Safety Limits

Related substance profiles

  • Bacopa Monnieri — Standardized Bacopa monnieri extracts improved memory measures in some 12-week trials. Dendrite and neurotransmitter mechanisms are mostly preclinical; the same benefit is not established across all cognitive domains or every product.
  • Alpha-GPC — Alpha-GPC is a choline source. It has been studied in Alzheimer’s disease and small exercise trials; cognitive benefits in healthy people and long-term safety remain uncertain.
  • Ginkgo Biloba — Findings on ginkgo for dementia symptoms are mixed. Prevention of dementia, cognitive enhancement in healthy people or relief of tinnitus has not been established; bleeding interactions require caution.
  • CDP-Choline — CDP-choline is a choline and nucleotide precursor. It has been examined in some memory studies; dopamine receptor findings are animal data and do not establish improved motivation in healthy people.
  • Piracetam — Piracetam is a synthetic racetam used as a medicine for cortical myoclonus in certain countries. Evidence is not equivalent for dementia, stroke or cognitive enhancement in healthy people; prescribing conditions and renal function matter.
  • noopept — Noopept is a synthetic dipeptide derivative. Neurotrophic and glutamate mechanisms are mainly based on animal or cell experiments. Limited studies in patients do not establish benefit in healthy people or clinical efficacy 1000 times greater than piracetam.
  • creatine — Creatine monohydrate has been studied in cognitive research. Some tests show positive results, but general cognitive benefit remains unestablished; study methods, participants and measured outcomes matter.
  • Acetyl-L-Carnitine — Acetyl-L-carnitine plays a role in energy metabolism. Cognitive and neuropathy research findings vary by condition; cognitive benefits in healthy young people remain uncertain.
  • Huperzine A — Huperzine A inhibits acetylcholinesterase. Alzheimer trial results are mixed; standard efficacy or a use protocol has not been established for healthy people.
  • vinpocetine — Vinpocetine is a vasoactive synthetic compound studied in older patient trials. Rapid focus or memory enhancement in healthy people is not established; a blood-flow mechanism alone does not establish cognitive benefit.
  • aniracetam — Aniracetam is a fat-soluble racetam. Memory and anxiety mechanisms have mostly been studied preclinically; efficacy and a safe regimen in healthy people have not been established.
  • DMAE — DMAE has not been established as an acetylcholine precursor or as improving focus or memory in healthy people. Older small studies were negative or uncertain; cosmetic use does not establish oral cognitive benefits.
  • Oxiracetam — Oxiracetam is a synthetic racetam. Post-stroke prevention and acute traumatic-brain-injury studies concern different patients, products and routes; they do not establish cognitive benefits or personal-use protocols for healthy people.
  • Centella asiatica (Gotu Kola) — Centella asiatica (Gotu Kola) is a traditional herb. Small human studies examined cognition and startle responses; BDNF and neuroplasticity findings are mostly animal data.
  • pramiracetam — Pramiracetam is a synthetic racetam with investigated cholinergic mechanisms. Small, older clinical trials do not establish general cognitive enhancement or superiority to other racetams.
  • L-Tyrosine — L-Tyrosine is an amino acid used in catecholamine synthesis. Small, variable human experiments studied selected tasks under stress; they do not establish general cognitive enhancement, a personal dose or equivalence with NALT.
  • Berberine — Berberine is a plant alkaloid studied for metabolic effects. Some human data concern blood glucose; cognitive benefits in healthy people or protection against Alzheimer’s disease have not been established.

Filter this category in the encyclopedia · Open the relevant tool

Energy, fatigue and performance

Alertness, physical performance and mental fatigue are different results. Consider the conditions and participant group in the study, together with the profile of the compound used.

Reading path

  1. Mitochondria and Brain Energy: Mechanisms and Evidence
  2. Athlete Brain Performance: Supplement Evidence and Limits

Related substance profiles

  • rhodiola rosea — Rhodiola rosea is traditionally used for fatigue and stress. Some small trials report benefits but have methodological problems; NCCIH finds insufficient reliable evidence to determine health benefits.
  • N-Acetyl L-Tyrosine — NALT is acetylated L-tyrosine. Findings on cognition under stress largely concern free L-tyrosine; the same efficacy, dose or onset has not been established for NALT.
  • Panax Ginseng — Small acute trials of Panax ginseng measured mental fatigue and test performance. They do not establish sustained cognitive enhancement; Panax quinquefolius findings do not directly transfer to Korean ginseng, a different species.
  • Phenylpiracetam — Phenylpiracetam is a synthetic racetam. Stimulant and memory mechanisms have been studied in animals; cognitive superiority or a safe cycling regimen in healthy people has not been established.
  • Sulbutiamine — Sulbutiamine is a synthetic thiamine derivative studied for fatigue. Motivation or cognitive enhancement in healthy people is not established; a drug authorization does not validate every proposed use.
  • cordyceps — Cordyceps species and different mushroom blends have been examined in exercise research. Human findings are limited and mixed; ATP and immune mechanisms alone do not establish improved clinical performance.
  • shilajit — Purified shilajit has been investigated for hormonal measures in specific small human trials. It is not an established general treatment for brain energy, mineral deficiency or CoQ10 bioavailability; purity and long-term safety matter.
  • Coenzyme Q10 — CoQ10 participates in cellular energy metabolism. This biochemical role does not prove supplementation improves memory or energy in healthy people; clinical findings are bounded by patient group and formulation.
  • modafinil — Modafinil is a prescription wakefulness medicine for excessive sleepiness associated with specified sleep disorders. It does not replace sleep; cognitive benefits in healthy people vary by task and baseline condition and do not guarantee superior performance across all domains.
  • Tongkat Ali — Tongkat Ali has been studied for hormonal and stress measures. Small short-term trials do not establish cognitive enhancement; long-term safety and differences among products remain uncertain.

Filter this category in the encyclopedia · Open the relevant tool

Sleep and rest

Falling asleep, total sleep time, and next-day functionality are not the same measurement. Read our articles about sleep together with the safety and interaction sections in the substance profiles.

Reading path

  1. Sleep and Nootropics: Human Studies and Limits
  2. Caffeine and L-Theanine: Attention Studies and Their Limits

Related substance profiles

  • Mg L-Threonate — Magnesium L-threonate has been studied for brain magnesium and synaptic plasticity in animals. Human cognition and sleep findings are promising but limited.
  • melatonin — Melatonin is a hormone regulating circadian timing. It may help some sleep disorders and jet lag; lower doses have not been shown to work better in every situation.
  • Apigenin — Apigenin is a flavonoid found in chamomile and other plants. Findings on calming mechanisms are mostly preclinical; chamomile extract trials do not establish pure apigenin as a sleep or anxiety treatment.
  • phenibut — High-quality modern controlled human evidence for phenibut in anxiety and sleep is limited. The US FDA does not recognize phenibut as a dietary supplement ingredient. CDC poison-center data report serious toxicity, coma and deaths; these observational data do not quantify risk across all users.
  • Valerian (Valerian) — Valerian is an herb studied for sleep problems; human findings are inconsistent. It may cause mental dullness and should not be combined with alcohol or sedatives.

Filter this category in the encyclopedia · Open the relevant tool

Mood, stress and motivation

Stress scales, subjective well-being, and clinical diagnoses should be distinguished. This topic group is for research reading; It does not offer diagnosis or treatment selection.

Reading path

  1. Stress and Cortisol: Human Measurements and Supplement Research
  2. Dopamine and Motivation: Limits of Nootropic Evidence
  3. Depression and Anxiety: Evidence and Risks of Natural Supplements

Related substance profiles

  • ashwagandha — Withania somnifera. Some short-term trials report improvements in stress and sleep measures; testosterone findings come from limited groups of men.
  • L-Theanine — L-theanine is an amino acid found in tea. Small human studies examined stress, sleep and attention with caffeine; treatment of every anxiety condition or prevention of caffeine adverse effects has not been established.
  • Phosphatidylserine — Crook et al. (1991) studied bovine-brain PS at 300 mg/day for 12 weeks in 149 people with age-associated memory complaints. The result cannot be directly generalized to all soy or sunflower products or healthy young people.
  • 5-HTP — 5-HTP is a serotonin precursor. Human evidence for mood, sleep and appetite is limited; it carries a serious interaction risk with serotonergic medicines.
  • Mucuna Pruriens — Mucuna pruriens seeds contain levodopa. Preparations and L-DOPA content vary. Parkinson’s and infertility studies do not establish a motivation benefit in healthy people.
  • Saffron Extract — Small short-term depression trials of saffron are promising. Finding no difference from antidepressants does not establish clinical equivalence; the clinical contribution of serotonin or GABA mechanisms in humans is unconfirmed.
  • St. John's wort — The Linde et al. (2008) Cochrane review included 29 trials and 5489 patients. Tested St John’s wort extracts outperformed placebo and had similar outcomes to antidepressants; findings cannot automatically generalize to all products, depression severities or individual treatment.
  • taurine — Taurine is a natural amino sulfonic acid. Neurotransmission mechanisms are investigated; adequate clinical evidence for treating insomnia or anxiety or improving cognition in humans is lacking.
  • Melisa (Lemon Balm) — Small human studies have examined lemon balm for calmness and stress measures; general cognitive superiority or treatment of anxiety has not been established. Extracts are not interchangeable, and the GABA-T mechanism does not guarantee overall safety.
  • Vitamin D3 — Vitamin D3 is important for bone and calcium metabolism; treating deficiency depends on medical assessment. Associations of low levels with depression or cognitive decline do not establish that supplements prevent or treat these conditions.

Filter this category in the encyclopedia · Open the relevant tool

Neuroplasticity and brain health

Mechanistic findings from cell and animal studies do not imply clinical benefit in humans. Study design and the limits of the evidence are particularly important in this topic.

Reading path

  1. Neuroplasticity: mechanisms, human evidence and research limits
  2. Brain Aging: Limits of Nootropic Research
  3. Gut-Brain Axis and Cognitive Performance

Related substance profiles

  • Lion's Mane — Lion’s Mane (Hericium erinaceus) has been examined in small cognition and mood studies. NGF, BDNF and neuroplasticity findings are mostly cell or animal data; they do not establish human neurogenesis or dementia prevention.
  • Omega-3 DHA/EPA — EPA and DHA are long-chain omega-3 fatty acids; DHA is an important brain membrane component. They are not a universal supplement treatment for depression or cognitive decline; clinical results vary by population and formulation.
  • Uridine Monophosphate — Uridine is a nucleoside involved in membrane synthesis; UMP is its phosphorylated form. Synaptic findings with choline and DHA mostly come from animals; “Mr. Happy Stack” is not an established cognitive protocol for healthy humans.
  • curcumin — Curcumin is a turmeric polyphenol. Human findings on cognition and mood are mixed; BDNF and amyloid mechanisms do not establish Alzheimer’s prevention. Products with enhanced bioavailability have been linked to liver injury.
  • NMN — NMN is an NAD+ precursor. Small human trials have explored metabolic outcomes; extending human lifespan or improving cognition has not been established.
  • resveratrol — Resveratrol is a plant polyphenol. Small human studies have explored blood-flow and memory measures; human lifespan extension or established anti-aging synergy with NMN has not been demonstrated.
  • NAC (N-Acetyl Cysteine) — NAC is involved in cysteine and glutathione metabolism. It has a medical use in acetaminophen poisoning; it is not an equally established general treatment for neuroprotection, OCD or addiction.
  • PQQ (Pyrrolo Quinoline Quinone) — PQQ is a redox compound. Mitochondrial biogenesis and neuroprotection findings are mostly cellular or animal data; new brain mitochondria or BDNF-mediated cognitive benefit in humans have not been established.

Filter this category in the encyclopedia · Open the relevant tool